EC Number |
Disease |
PubMed ID |
Title of Publication |
Category |
Confidence Level |
---|
2.3.1.22 | Fabry Disease |
209782 |
Reexpression of HPRT activity following cell fusion with polyethylene glycol. |
causal interaction ongoing research unassigned |
1 2 0 |
2.3.1.22 | Congenital Disorders of Glycosylation |
8808595 |
Mutations in the MGAT2 gene controlling complex N-glycan synthesis cause carbohydrate-deficient glycoprotein syndrome type II, an autosomal recessive disease with defective brain development. |
unassigned |
0 |
2.3.1.22 | Liver Neoplasms |
9661906 |
Progression of hepatic neoplasms is severely retarded in mice lacking the bisecting N-acetylglucosamine on N-glycans: evidence for a glycoprotein factor that facilitates hepatic tumor progression. |
ongoing research unassigned |
3 0 |
2.3.1.22 | Neoplasms |
9661906 |
Progression of hepatic neoplasms is severely retarded in mice lacking the bisecting N-acetylglucosamine on N-glycans: evidence for a glycoprotein factor that facilitates hepatic tumor progression. |
ongoing research unassigned |
3 0 |
2.3.1.22 | Neoplasms |
10866326 |
New evidence for an extra-hepatic role of N-acetylglucosaminyltransferase III in the progression of diethylnitrosamine-induced liver tumors in mice. |
causal interaction ongoing research therapeutic application unassigned |
1 2 1 0 |
2.3.1.22 | Neoplasms |
11986323 |
Truncated, inactive N-acetylglucosaminyltransferase III (GlcNAc-TIII) induces neurological and other traits absent in mice that lack GlcNAc-TIII. |
causal interaction unassigned |
1 0 |
2.3.1.22 | Congenital, Hereditary, and Neonatal Diseases and Abnormalities |
12417412 |
Mice with a homozygous deletion of the Mgat2 gene encoding UDP-N-acetylglucosamine:alpha-6-D-mannoside beta1,2-N-acetylglucosaminyltransferase II: a model for congenital disorder of glycosylation type IIa. |
ongoing research therapeutic application unassigned |
4 2 0 |
2.3.1.22 | Obesity |
12621063 |
MGAT2, a monoacylglycerol acyltransferase expressed in the small intestine. |
ongoing research therapeutic application unassigned |
3 1 0 |
2.3.1.22 | Obesity |
12730219 |
Properties of the mouse intestinal acyl-CoA:monoacylglycerol acyltransferase, MGAT2. |
therapeutic application unassigned |
4 0 |
2.3.1.22 | Neoplasms |
14633700 |
Reduced hepatocyte proliferation is the basis of retarded liver tumor progression and liver regeneration in mice lacking N-acetylglucosaminyltransferase III. |
causal interaction ongoing research unassigned |
1 3 0 |